G. Maio et al., Hepatitis C virus infection and alanine transaminase levels in the generalpopulation: a survey in a southern Italian town, J HEPATOL, 33(1), 2000, pp. 116-120
Background/Aim: The aim of the study was to estimate the prevalence, risk f
actors and genotype distribution of hepatitis C virus (HCV) in the general
population older than 5 years of age in a southern Italian town. The positi
ve predictive value of alanine transaminase (ALT) screening in identifying
HCV positive subjects was also assessed.
Methods: Cluster random sampling from the census of the general population
was used. ELISA and RIBA tests assessed the presence of anti-HCV; nested re
verse transcription polymerase chain reaction (RT-PCR) was used to identify
HCV-RNA; genotyping was performed by INNO-LIPA III. The association linkin
g anti-HCV seropositivity with potential risk factors was assessed by multi
ple logistic regression analysis.
Results: Among the 488 subjects enrolled, 79 (16.2%) were anti-HCV positive
. The prevalence increased from 1.2% in subjects 6-29 years of age to 42.1%
in those greater than or equal to 60 years. Forty percent of these positiv
e subjects also had abnormal ALT level and 54.4% were HCV RNA positive by P
CR, The positive predictive value of the ALT test in identifying anti-HCV p
ositive subjects was 65%; however, it was 46.7% in subjects younger than 60
years of age and 90.5% in those 60 or older. Genotype Ib was detected in 7
4% of subjects, type 2c in 23.3%, and type 1a in 2.3%. The only two variabl
es significantly associated with HCV seropositivity in multivariate analysi
s were age older than 45 years (O.R. 8.5; CI 95% = 3.0-24.1) and past use o
f glass syringes (O.R. 3.4; CI 95% = 1.5-7.6).
Conclusions: These findings confirm that HCV infection is endemic in southe
rn Italy, particularly among the elderly. Percutaneous exposure, such as in
jections with nondisposable, multiple-use, glass syringes used in the past
for medical purposes may have played a major role in the spread of HCV infe
ction. ALT screening is not useful in detecting HCV positive subjects in th
e general population, particularly among subjects who could benefit from an
tiviral therapy.